Chemogenetic activation of corticotropin-releasing hormone neurons in the paraventricular nucleus of the hypothalamus (PVNCRH) neurons during specific circadian phases restores glucocorticoid rhythmicity, suppresses tumor growth, and enhances intratumoral CD8+ T cell infiltration [166]. The gene discussed is CRH; the disease is neoplasm.